-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Axsome Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2014 to 2024.
- Axsome Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending December 31, 2024 was $22M, a 26.5% increase year-over-year.
- Axsome Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending December 31, 2024 was $85.2M, a 36.1% increase year-over-year.
- Axsome Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $85.2M, a 36.1% increase from 2023.
- Axsome Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $62.6M, a 66% increase from 2022.
- Axsome Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $37.7M, a 181266% increase from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)